These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 8721892)
1. Acute treatment response in outpatients with panic disorder: high versus low depressive symptoms. Black DW; Wesner R; Bowers W; Monahan P; Gabel J Ann Clin Psychiatry; 1995 Dec; 7(4):181-8. PubMed ID: 8721892 [TBL] [Abstract][Full Text] [Related]
2. A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder. Black DW; Wesner R; Bowers W; Gabel J Arch Gen Psychiatry; 1993 Jan; 50(1):44-50. PubMed ID: 8422221 [TBL] [Abstract][Full Text] [Related]
3. Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients. Asnis GM; Hameedi FA; Goddard AW; Potkin SG; Black D; Jameel M; Desagani K; Woods SW Psychiatry Res; 2001 Aug; 103(1):1-14. PubMed ID: 11472786 [TBL] [Abstract][Full Text] [Related]
4. An open trial of fluvoxamine therapy for panic disorder complicated by depression. Spiegel DA; Saeed SA; Bruce TJ J Clin Psychiatry; 1996; 57 Suppl 8():37-40; discussion 40-1. PubMed ID: 8698679 [TBL] [Abstract][Full Text] [Related]
5. Predictors of short-term treatment response in 66 patients with panic disorder. Black DW; Wesner RB; Gabel J; Bowers W; Monahan P J Affect Disord; 1994 Apr; 30(4):233-41. PubMed ID: 8014323 [TBL] [Abstract][Full Text] [Related]
6. Cognitive-behavioral group therapy for panic disorder in the general clinical setting: a naturalistic study with 1-year follow-up. Martinsen EW; Olsen T; Tønset E; Nyland KE; Aarre TF J Clin Psychiatry; 1998 Aug; 59(8):437-42; quiz 443. PubMed ID: 9721829 [TBL] [Abstract][Full Text] [Related]
7. Fluvoxamine pharmacotherapy of anxiety disorders in later life: preliminary open-trial data. Wylie ME; Miller MD; Shear MK; Little JT; Mulsant BH; Pollock BG; Reynolds CF J Geriatr Psychiatry Neurol; 2000; 13(1):43-8. PubMed ID: 10753007 [TBL] [Abstract][Full Text] [Related]
8. Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group. Michelson D; Lydiard RB; Pollack MH; Tamura RN; Hoog SL; Tepner R; Demitrack MA; Tollefson GD Am J Psychiatry; 1998 Nov; 155(11):1570-7. PubMed ID: 9812120 [TBL] [Abstract][Full Text] [Related]
9. Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone. de Beurs E; van Balkom AJ; Lange A; Koele P; van Dyck R Am J Psychiatry; 1995 May; 152(5):683-91. PubMed ID: 7726307 [TBL] [Abstract][Full Text] [Related]
10. Fluvoxamine attenuates panic induced by 35% CO2 challenge. Pols HJ; Hauzer RC; Meijer JA; Verburg K; Griez EJ J Clin Psychiatry; 1996 Nov; 57(11):539-42. PubMed ID: 8968304 [TBL] [Abstract][Full Text] [Related]
11. Influence of panic-agoraphobic spectrum symptoms on treatment response in patients with recurrent major depression. Frank E; Shear MK; Rucci P; Cyranowski JM; Endicott J; Fagiolini A; Grochocinski VJ; Houck P; Kupfer DJ; Maser JD; Cassano GB Am J Psychiatry; 2000 Jul; 157(7):1101-7. PubMed ID: 10873918 [TBL] [Abstract][Full Text] [Related]
12. Global measures of outcome in a controlled comparison of pharmacological and psychological treatment of panic disorder and agoraphobia in primary care. Sharp DM; Power KG; Simpson RJ; Swanson V; Anstee JA Br J Gen Pract; 1997 Mar; 47(416):150-5. PubMed ID: 9167318 [TBL] [Abstract][Full Text] [Related]
13. Effect of fluvoxamine on panic disorder. Hoehn-Saric R; McLeod DR; Hipsley PA J Clin Psychopharmacol; 1993 Oct; 13(5):321-6. PubMed ID: 8227490 [TBL] [Abstract][Full Text] [Related]
14. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia. Bakish D; Hooper CL; Filteau MJ; Charbonneau Y; Fraser G; West DL; Thibaudeau C; Raine D Psychopharmacol Bull; 1996; 32(1):135-41. PubMed ID: 8927663 [TBL] [Abstract][Full Text] [Related]
15. Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages. Moroz G; Rosenbaum JF J Clin Psychiatry; 1999 Sep; 60(9):604-12. PubMed ID: 10520979 [TBL] [Abstract][Full Text] [Related]
16. Fluvoxamine treatment of obsessive-compulsive disorder. Perse TL; Greist JH; Jefferson JW; Rosenfeld R; Dar R Am J Psychiatry; 1987 Dec; 144(12):1543-8. PubMed ID: 3120604 [TBL] [Abstract][Full Text] [Related]
17. Issues in the assessment of treatment response in panic disorder with special reference to fluvoxamine. Ninan PT J Clin Psychiatry; 1997; 58 Suppl 5():24-31. PubMed ID: 9184624 [TBL] [Abstract][Full Text] [Related]
18. An open-label trial of nefazodone in high comorbidity panic disorder. DeMartinis NA; Schweizer E; Rickels K J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561 [TBL] [Abstract][Full Text] [Related]
19. Pindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trial. Hirschmann S; Dannon PN; Iancu I; Dolberg OT; Zohar J; Grunhaus L J Clin Psychopharmacol; 2000 Oct; 20(5):556-9. PubMed ID: 11001241 [TBL] [Abstract][Full Text] [Related]
20. Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder. Broocks A; Bandelow B; Pekrun G; George A; Meyer T; Bartmann U; Hillmer-Vogel U; Rüther E Am J Psychiatry; 1998 May; 155(5):603-9. PubMed ID: 9585709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]